Veterinary Medicines

Nobivac Tricat Trio, Lyophilisate and Solvent for Suspension for Injection for Cats

Authorised
  • Feline panleucopenia virus, strain MW-1, Live
  • Felid herpesvirus 1, strain G2620A, Live
  • Feline calicivirus, strain F9, Live
Download as PDF

Product identification

Medicine name:
Nobivac Tricat Trio, Lyophilisate and Solvent for Suspension for Injection for Cats
Nobivac Tricat Trio lyofilisat og solvens til injektionsvæske, suspension
Active substance:
  • Feline panleucopenia virus, strain MW-1, Live
  • Felid herpesvirus 1, strain G2620A, Live
  • Feline calicivirus, strain F9, Live
Target species:
  • Cat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Feline panleucopenia virus, strain MW-1, Live
    4.30
    log10 tissue culture infective dose 50
    /
    1.00
    Dose
  • Felid herpesvirus 1, strain G2620A, Live
    5.20
    log10 plaque forming unit(s)
    /
    1.00
    Dose
  • Feline calicivirus, strain F9, Live
    4.60
    log10 plaque forming unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI06AD04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Package description:
  • (ID4) 50 Dose; 50 millilitre(s): Box (Cardboard) with 50 Box (Cardboard) each with 1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)
  • (ID2) 10 millilitre(s); 10 Dose: Box (Cardboard) with 10 Box (Cardboard) each with 1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)
  • (ID1) 5 Dose; 5 millilitre(s): Box (Cardboard) with 5 Box (Cardboard) each with 1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)
  • (ID3) 25 millilitre(s); 25 Dose: Box (Cardboard) with 25 Box (Cardboard) each with 1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)
  • (ID5) 5 Dose; 5 millilitre(s): Box (plastic) with 5 Box (plastic) each with 1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)
  • (ID6) 10 millilitre(s); 10 Dose: Box (plastic) with 10 Box (plastic) each with 1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)
  • (ID7) 25 millilitre(s); 25 Dose: Box (plastic) with 25 Box (plastic) each with 1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)
  • (ID8) 50 Dose; 50 millilitre(s): Box (plastic) with 50 Box (plastic) each with 1 Bottle (Glass) with 1 Dose and 1 Bottle (Glass) with 1 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 40161
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0240/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/03/2023
Download
Danish (PDF)
Published on: 19/12/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."